Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
EL Elaia AFACCVDV45 people · Follows rounds	88🔒	Paris	FR	Seed–Series C	$108K – $1.6M	+ Add to CRM
RA Rabo Corporate Venturing MSAVBVBV57 people · Follows rounds	88🔒	Utrecht	NL	Seed–Series B	$1.1M – $5.5M	+ Add to CRM
NO Novo Holdings ANALAEAS47 people	88🔒	Copenhagen	DK	Seed–Late Stage	$1.1M – $54M	+ Add to CRM
EQ EQT Life Sciences MKPFSMAD66 people · Leads rounds	88🔒	Amsterdam	NL	Seed–Late Stage	$11M – $66M	+ Add to CRM
JO Joyance Partners BWMEWLAS17 people	88🔒	Berlin	DE	Pre-Seed–Series A	—	+ Add to CRM
WE We Ventures APJJJLJY19 people	88🔒	Seoul	KR	Seed–Series B	—	+ Add to CRM
SM SMBC Venture Capital IKIIJYKM27 people · Follows rounds	88🔒	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
AR Artesian ACDGFZGP42 people · Leads rounds	88🔒	Sydney	AU	Pre-Seed–Growth	$20M	+ Add to CRM
EI Eight Roads Ventures DHLCSBVB33 people	88🔒	Mumbai	IN	Seed–Late Stage	$5M – $30M	+ Add to CRM
UN UntroD Capital HTAWDKNH38 people · Leads rounds	88🔒	Tokyo	JP	Seed–Growth	—	+ Add to CRM
XA XAnge ADCBGDGM22 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Series B	$1.1M – $10.8M	+ Add to CRM
SO Sofina HBAMALEK57 people · Follows rounds	88🔒	Brussels	BE	Seed–Late Stage	$100M – $300M	+ Add to CRM
BL Blume Ventures KRSNAAAF32 people	88🔒	Mumbai	IN	Seed–Series B	$50K – $300K	+ Add to CRM
SE Seventure Partners IDBRDMEF19 people · Leads rounds	88🔒	Paris	FR	Seed–Growth	—	+ Add to CRM
HE HealthCap AVAFBOCK33 people	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
CO Colopl Next HHSYHSAM17 people · Follows rounds	88🔒	Tokyo	JP	Seed–Growth	—	+ Add to CRM
SB SBI Investment Korea Co. Ltd. JA안2 people	88🔒	Seoul	KR	Series A–Series C	$200K – $10M	+ Add to CRM
GI Giant Ventures Global Llp BEGAHTML30 people · Leads rounds	88🔒	London	GB	Pre-Seed–Growth	$10M – $20M	+ Add to CRM
ME Metaplanet JTRMSBKM4 people · Follows rounds	88🔒	Tallinn	EE	Seed–Series B	$500K – $10M	+ Add to CRM
HU Hummingbird Ventures BVFILLD33 people · Follows rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	$500K – $10M	+ Add to CRM
NL NLC BMBPOMJH43 people	88🔒	Amsterdam	NL	Pre-Seed–Seed	—	+ Add to CRM
ON OneVentures ABMDPKBS44 people · Leads rounds	88🔒	Sydney	AU	Seed–Late Stage	$3.3M – $13.2M	+ Add to CRM
GI Gimv AJBDBTBW40 people · Leads rounds	88🔒	Antwerp	BE	Growth	$20M – $400M	+ Add to CRM
AB Abingworth ASGLJPKV44 people	88🔒	London	GB	Seed–Late Stage	$15M – $30M	+ Add to CRM

Elaia

ParisSeed–Series C$108K – $1.6M

AFACCVDV45 people

Rabo Corporate Venturing

UtrechtSeed–Series B$1.1M – $5.5M

MSAVBVBV57 people

Novo Holdings

CopenhagenSeed–Late Stage$1.1M – $54M

ANALAEAS47 people

EQT Life Sciences

AmsterdamSeed–Late Stage$11M – $66M

MKPFSMAD66 people

Joyance Partners

BerlinPre-Seed–Series A

BWMEWLAS17 people

We Ventures

SeoulSeed–Series B

APJJJLJY19 people

SMBC Venture Capital

TokyoPre-Seed–Late Stage

IKIIJYKM27 people

Artesian

SydneyPre-Seed–Growth$20M

ACDGFZGP42 people

Eight Roads Ventures

MumbaiSeed–Late Stage$5M – $30M

DHLCSBVB33 people

UntroD Capital

TokyoSeed–Growth

HTAWDKNH38 people

XAnge

ParisPre-Seed–Series B$1.1M – $10.8M

ADCBGDGM22 people

Sofina

BrusselsSeed–Late Stage$100M – $300M

HBAMALEK57 people

Blume Ventures

MumbaiSeed–Series B$50K – $300K

KRSNAAAF32 people

Seventure Partners

ParisSeed–Growth

IDBRDMEF19 people

HealthCap

StockholmSeed–Growth

AVAFBOCK33 people

Colopl Next

TokyoSeed–Growth

HHSYHSAM17 people

SBI Investment Korea Co. Ltd.

SeoulSeries A–Series C$200K – $10M

JA안2 people

Giant Ventures Global Llp

LondonPre-Seed–Growth$10M – $20M

BEGAHTML30 people

Metaplanet

TallinnSeed–Series B$500K – $10M

JTRMSBKM4 people

Hummingbird Ventures

BrusselsPre-Seed–Late Stage$500K – $10M

BVFILLD33 people

NLC

AmsterdamPre-Seed–Seed

BMBPOMJH43 people

OneVentures

SydneySeed–Late Stage$3.3M – $13.2M

ABMDPKBS44 people

Gimv

AntwerpGrowth$20M – $400M

AJBDBTBW40 people

Abingworth

LondonSeed–Late Stage$15M – $30M

ASGLJPKV44 people

Data sourced from public filings and firms' own websites — see our methodology.